Ras oncoprotein inhibitors: the discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex.
暂无分享,去创建一个
L. Perkins | S. Liberles | J. Brown | M. Snow | C. Kissinger | M. Senior | P. Kirschmeier | J. Catino | R. Doll | S. Webber | S. Remiszewski | E. Brown | B. Pramanik | D. Carr | E. Huang | A. Tsarbopoulos | A. Taveras | L. James | R. Love | A. Ganguly | S. Fuhrman | L. Heimark | Joan E. Brown | B. Vibulbhan | B. Bauer | E. Villafranca | C. A. Evans | J. D. Rosario | Y. S. Wang | W. Sisson | D. Cesarz | R. Aust | J. del Rosario | V. Girijavallabhan | C. Nash | D. Delisle | Hendrickson Thomas | Yu‐Sen Wang
[1] P. Kirschmeier,et al. Synthesis and evaluation of pyrazolo[3,4-b]quinoline ribofuranosides and their derivatives as inhibitors of oncogenic Ras , 1996 .
[2] L. Feig,et al. Guanine-nucleotide exchange factors: a family of positive regulators of Ras and related GTPases. , 1994, Current opinion in cell biology.
[3] P. Kraulis,et al. Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy. , 1994, Biochemistry.
[4] A. Cherniack,et al. Phosphorylation of the Ras nucleotide exchange factor son of sevenless by mitogen-activated protein kinase. , 1994, The Journal of biological chemistry.
[5] S. Liberles,et al. Studies of the Ras-GDP and Ras-GTP noncovalent complexes by electrospray mass spectrometry , 1993 .
[6] Chuan Yi Tang,et al. A 2.|E|-Bit Distributed Algorithm for the Directed Euler Trail Problem , 1993, Inf. Process. Lett..
[7] E. Laue,et al. Sequential assignment of the backbone nuclei (1H,15N and13C) of c-H-ras p21 (1–166).GDP using a novel 4D NMR strategy , 1992, Journal of biomolecular NMR.
[8] T. Covey,et al. Mass spectrometric detection of the noncovalent GDP-bound conformational state of the human H-ras protein , 1992 .
[9] H. Kung,et al. Nerve growth factor stimulation of the Ras-guanine nucleotide exchange factor and GAP activities. , 1992, Science.
[10] N. Brown,et al. Interaction of GTP derivatives with cellular and oncogenic ras-p21 proteins. , 1991, Journal of medicinal chemistry.
[11] S H Kim,et al. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP. , 1991, Journal of molecular biology.
[12] W. Kabsch,et al. Refined crystal structure of the triphosphate conformation of H‐ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. , 1990, The EMBO journal.
[13] M. Barbacid,et al. ras oncogenes: their role in neoplasia , 1990, European journal of clinical investigation.
[14] Y. Kaziro,et al. Induction of neurite formation in PC12 cells by microinjection of proto-oncogenic Ha-ras protein preincubated with guanosine-5'-O-(3-thiotriphosphate) , 1987, Molecular and cellular biology.
[15] S. Hattori,et al. Neutralizing monoclonal antibody against ras oncogene product p21 which impairs guanine nucleotide exchange , 1987, Molecular and cellular biology.
[16] K. Wüthrich. NMR of proteins and nucleic acids , 1988 .
[17] A. Hall,et al. The effect of Mg2+ on the guanine nucleotide exchange rate of p21N-ras. , 1986, The Journal of biological chemistry.
[18] C. Rondestvedt,et al. Rapid Preparation of Chloroarylhydroxylamines by Hydrazine-Palladium Reduction of Chloronitroarenes , 1977 .
[19] W. A. Sexton,et al. The relationship between the constitution and the effect of chemical compounds on plant growth. 1. 2-Phenoxyethylamine derivatives. , 1949, The Biochemical journal.